Barrington analyst Alexander Paris reiterated a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $112.00. The ...

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended January 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key ...

During the third quarter of fiscal 2025, despite inflationary challenges, HealthEquity experienced solid growth in HSA balances, driven by a significant increase in invested assets, which now ...

Keybank National Association OH bought a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the 4th quarter, ...

DRAPER, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation today announced the first recipients of grants from their inaugural grant cycle, and the application timeline ...

We came across a bullish thesis on HealthEquity, Inc. (HQY) on Substack by Francesco Ferrari. In this article, we will ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of HealthEquity Inc (Symbol: HQY) entered into oversold territory, hitting an RSI reading of 28 ...

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid third-quarter fiscal 2025 performance and strength in Health Savings Accounts (HSA), is ...

Charitable non-profits nationwide receive grants to advance healthcare, financial literacy, mental health, and basic human needs; Applicants encouraged to apply for next round of funding DRAPER, Utah, ...

J.P. Morgan analyst Anne Samuel maintained a Buy rating on Health Catalyst (HCAT – Research Report) yesterday and set a price target of $9.00.